Comper Wayne D, Russo Leileata M
Department of Biochemistry and Molecular Biology, Monash University, Victoria, Australia.
Curr Opin Nephrol Hypertens. 2009 Jul;18(4):336-42. doi: 10.1097/MNH.0b013e32832cb96a.
There is currently a major debate on the mechanisms of albuminuria, and this review appraises recent studies in this area.
The traditional view of albuminuria is that it is the result of damage to an essentially impermeable glomerular barrier. However, over the years, critical evidence for this traditional model has been shown to be flawed. An alternative explanation has evolved in which the glomerular filter governs albumin permeability by size selectivity alone. This means that the filter offers a significant barrier to albumin, but it is imperfect - the barrier leaks albumin. The virtue of this leakage is that it endows the filter an in-built anticlogging mechanism. The filtered albumin, if not rescued, would be excreted at nephrotic levels in the urine. There is evidence that proximal tubular cells participate in retrieving most of this filtered albumin to return it back to the blood supply intact. A small amount of the filtered albumin is not retrieved but directed toward lysosomal degradation, and the peptide products are exocytosed into the tubular lumen and excreted.
In acquired and chemically induced kidney disease, albuminuria is the result of dysfunction in proximal tubular cell processing of albumin rather than alterations in glomerular permeability.
目前关于蛋白尿的机制存在重大争论,本综述对该领域的近期研究进行评估。
蛋白尿的传统观点认为,它是本质上不可渗透的肾小球屏障受损的结果。然而,多年来,这一传统模型的关键证据已被证明存在缺陷。一种替代解释逐渐形成,即肾小球滤过器仅通过大小选择性来控制白蛋白通透性。这意味着滤过器对白蛋白构成了显著屏障,但并不完美——屏障会泄漏白蛋白。这种泄漏的好处是它赋予滤过器一种内置的防堵塞机制。滤过的白蛋白如果不被回收,将以肾病水平在尿液中排出。有证据表明近端肾小管细胞参与回收大部分滤过的白蛋白,使其完整地返回血液循环。少量滤过的白蛋白未被回收,而是被导向溶酶体降解,肽产物被胞吐到肾小管腔并排出。
在获得性和化学诱导的肾脏疾病中,蛋白尿是近端肾小管细胞处理白蛋白功能障碍的结果,而非肾小球通透性改变所致。